Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Paper

Editor's Choice - Free Access

Psychometric Properties of the Borderline Symptom List (BSL)

Bohus M.a · Limberger M.F.a · Frank U.b · Chapman A.L.c · Kühler T.d · Stieglitz R.-D.e

Author affiliations

aDepartment of Psychosomatics and Psychotherapy, Central Institute of Mental Health Mannheim, Mannheim, and bDepartment of Psychology, Albert Ludwig University Freiburg, Freiburg, Germany; cDepartment of Psychology, Simon Fraser University, Burnaby, B.C., Canada; dPsychiatric-Psychotherapeutic Hospital for Women Meissenberg, Zug, and eUniversity Psychiatric Outpatient Department, Basel, Switzerland

Corresponding Author

Prof. Dr. M. Bohus

Department of Psychosomatics and Psychotherapy

Central Institute of Mental Health, J 5

DE–68159 Mannheim (Germany)

Tel. +49 621 1703 4001, Fax +49 621 1703 4005, E-Mail martin.bohus@zi-mannheim.de

Related Articles for ""

Psychopathology 2007;40:126–132

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Background: The Borderline Symptom List (BSL) was developed as a self-rating instrument to specifically quantify borderline-typical symptomatology. The items are based on the criteria of the DSM-IV, the Diagnostic Interview for Borderline Personality Disorder – revised version, the opinions of clinical experts and borderline patients. The psychometric properties and validity of the BSL have been investigated in several studies. Sampling and Methods: A total of 380 borderline patients and 204 healthy controls scored the items. A factor analysis of the BSL items suggests the following subscales: ‘self-perception’, ‘affect regulation’, ‘self-destruction’, ‘dysphoria’, ‘loneliness’, ‘intrusions’ and ‘hostility’. Results: Theinternal reliability as well as the test-retest reliability within 1 week are high. Different aspects of validity (e.g. comparison between groups) provide favorable results. Pre-post comparisons after 3 months of dialectical behavioral treatment reveal a significant reduction of the total score and of 5 of the 7 subscales. Conclusions: This indicates that the BSL is sensitive to therapeutically induced change of borderline-typical impairment.

© 2007 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: May 02, 2005
Accepted: February 13, 2006
Published online: January 11, 2007
Issue release date: February 2007

Number of Print Pages: 7
Number of Figures: 1
Number of Tables: 5

ISSN: 0254-4962 (Print)
eISSN: 1423-033X (Online)

For additional information: http://www.karger.com/PSP

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.